Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

Surgical Versus Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms

ANTONIOS KOUTRAS, ANGELIS PETEINARIS, SPYRIDON DAVAKIS, GEORGIOS KALINTERAKIS, IOANNIS TSILIKIS, NIKOLAOS GARMPIS, PROKOPIS-ANDREAS ZOTOS, ATHANASIOS CHIONIS, DIMITRIOS SCHIZAS, IOANNIS KARAVOKYROS, NIKOLAOS THOMAKOS, EMMANUEL KONTOMANOLIS and ATHANASIOS SYLLAIOS
Anticancer Research June 2020, 40 (6) 3065-3069; DOI: https://doi.org/10.21873/anticanres.14287
ANTONIOS KOUTRAS
1Department of Obstetrics and Gynecology, Laiko General Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANGELIS PETEINARIS
2Urology Department, Rio University Hospital, Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SPYRIDON DAVAKIS
3First Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GEORGIOS KALINTERAKIS
4Department of Orthopedics, 401 Generally Military Hospital of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS TSILIKIS
5Department of Interventional Radiology, Euroclinic, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIKOLAOS GARMPIS
3First Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PROKOPIS-ANDREAS ZOTOS
6Department of Surgery, University Hospital of Larisa, Larisa, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHANASIOS CHIONIS
1Department of Obstetrics and Gynecology, Laiko General Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIMITRIOS SCHIZAS
3First Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IOANNIS KARAVOKYROS
3First Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIKOLAOS THOMAKOS
7First Department of Obstetrics and Gynecology, Unit of Gynecologic Oncology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMMANUEL KONTOMANOLIS
8Department of Obstetrics and Gynecology, Democritus University of Thrace, Alexandroupolis, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHANASIOS SYLLAIOS
3First Department of Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nh_reas@hotmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Endometrial cancer is the most common gynecologic malignancy. The mainstay of treatment for endometrial cancer is total hysterectomy with bilateral salpingo-oophorectomy. Radiation and chemotherapy accompanied with progestins can also play a significant role in treatment. Lower urinary tract symptoms (LUTS) following therapy for endometrial cancer are an extremely difficult and challenging condition that deteriorates patients' quality of life. Current literature remains rather scarce regarding LUTS after therapy for endometrial cancer. This review aimed to investigate the incidence of LUTS in endometrial cancer treatment.

  • Endometrial cancer
  • surgical treatment
  • chemoradiotherapy
  • progestins
  • urinary tract symptoms

Endometrial cancer is a very commonly diagnosed malignancy of females even in women of reproductive age. It is the sixth most common malignancy worldwide with 61.880 new cases in 2019 in the United States and nearly 11,000 deaths from the disease, which primarily affects postmenopausal women (1, 2). Its incidence is increasing especially in socioeconomically developed countries including the United States where its rate reaches 19 cases in every 100,000 women (3). Similar rates are also observed in Eastern and Northern Europe. However, an extreme increase is observed in developing countries of South Africa and several countries in Asia (3).

The most frequent symptom is the post-menopausal bleeding. Other, not so rare symptoms include: irregular, unpredictable, heavy or prolonged (>7 days) periods, bleeding between periods, after sex and after menopause, pelvic pain and pressure, discharge, changes in bowel habits and urination frequency (4, 5).

The treatment of endometrial cancer may be surgical or conservative (6). The surgical treatment includes exploratory laparotomy, total hysterectomy with bilateral salpingo-oophorectomy, robotic total hysterectomy with pelvic and paraaortic lymphadenectomy, laparoscopic-assisted vaginal hysterectomy and total laparoscopic hysterectomy (7). Conservative treatment includes the use of progestins, radiation and/or chemotherapy based on staging of the disease (8). Concerning surgical treatment, the first choice is total hysterectomy with bilateral salpingo-oophorectomy. Three out of four women have early stage 1 cancer and they can be cured totally by surgery. The decision of whether the patient should undertake radiation and/or chemotherapy is mostly based on the histological results after the surgery (6). As for the conservative treatment, the use of progestins and more specifically medroxyprogesterone acetate (MPA), megestrol acetate (MA) and more recently levonorgestrel-release intrauterine devices (LNG-IUDs) is the most usual option for young women at reproductive age who wants to have children (8). According to American Cancer Society, chemotherapy and/or radiation therapy are also considered as a conservative option especially in women with endometrial cancer stage IV (IVA, IVB) (8).

Lower urinary tract symptoms (LUTS) are clinical symptoms that implicate the urethra, the urinary sphincter and the bladder. Recurrence is not a very unusual situation and one or more LUTS may coexist to a patient. According to the International Continence Society (ICS), LUTS can be divided into seven categories, from which the three main categories are the irritative, the obstructive and the postmicturition symptoms (9). The first one includes increased urgency/frequency of urination, nocturia, stress of incontinence, the second one comprises incomplete voiding, poor stream, retention and overflow incontinence (9). At last, the third category contains the feeling of incomplete emptying and postmicturition dribble (9). It appears that one third of patients with LUTS are improving, one third remains stable and one third is deteriorating. Their progress is variable and unpredictable, after the onset of the symptoms. Subjects with more severe urinary incontinence showed poorer scores on health-related quality of life and mental well-being assessments (10).

As for the quality of life and mental well-being, urinary incontinence is discriminated from all the other LUTS as it is one of the most important factors creating daily problems for women. It negatively impacts daily activities, social life, personal relationships, sleep and energy, and liquid consumption (11). Furthermore, it necessitates the use of protection and generates feelings of embarrassment (11).

This study aims to investigate and present the incidence of urinary tract symptoms in women who underwent a surgical procedure for endometrial cancer and those who had a conservative therapy with chemoradiotherapy or progestins.

Surgical Treatment and Urinary Tract Symptoms

Nowadays, it is essential to understand the long-term adverse effects of surgical interventions and in our review the urological adverse effects after hysterectomy, as women's life expectancy is increasing year by year (12). The surgical treatment is the most common and effective treatment for endometrial cancer and more specifically it is the first line treatment of dysfunctional uterine bleeding (DUB) (13). An excellent 5-year overall survival rate of 93% and 99% is achieved by the total hysterectomy with bilateral salpingoophorectomy with or without pelvic and/or paraaortic lymph node dissection (8, 14). Total abdominal hysterectomy affects the function of several pelvic organs such as the bladder due to the narrowness of pelvic anatomy affecting also the nerves (14). Brown et al. in a meta-analysis of 11 observational, controlled studies, concluded that the chances of developing urinary incontinence are 40% higher in women who have had a hysterectomy as compared with those who have had not (15).

Simple hysterectomy is the main cause of the development of symptoms of bladder dysfunction. Many women with simple hysterectomy are related with these symptoms. Parys BT et al. have reported in their review that there was an increase in the incidence of urinary symptoms from 58.3% pre-operatively to 75.0% post-operatively (16). Post-operative vesicourethral dysfunction and pelvic neuropathy are mainly associated with simple hysterectomy as several cross-sectional studies included in the previously referred review have indicated (16). The results of another prospective study, using questionnaires about hysterectomy-associated LUTS showed that there was no significant difference between women pre-operatively and after a 3-year post-operative follow-up, indicating that there is no risk for LUTS after surgery (17). Additionally, a prospective observational study that took place in the Netherlands, analyzed questionnaires of 430 women that had abdominal or vaginal hysterectomy and found out that after a 3-year follow-up, the participants who had a vaginal hysterectomy had significantly more urinary tract symptoms than the women who underwent an abdominal hysterectomy (18). Another meta-analysis in the Netherlands has shown that hysterectomy has an important role in the post-operative appearance of incontinence, without differentiating the type, as it increases the odds by approximately 30% (19). In Italy, case-control study in gynecological settings has shown that women with higher BMI and a history of total hysterectomy for endometrial cancer had increased risk of all types of urinary incontinence (20). A nationwide study in Taiwan comprised 2,410 women has shown that hysterectomy is indeed a risk factor for incontinence and that the prevalence of incontinence among women who underwent surgical procedure was about 42% and among women that did not, it was around 27% (21).

Non-surgical Treatment of Endometrial Cancer and Urinary Tract Symptoms

Radiotherapy is well established in the treatment algorithm of endometrial cancer, both as complementary therapy after surgical treatment or as definitive therapy for advanced endometrial cancer (stage IV). It is known that the bladder is at risk during radiation therapy for the treatment gynecologic malignancies. Most of the published literature reports that bladder symptoms result from pelvic radiation; these symptoms are mostly reported without validated measures (22). Many factors can determine whether a woman is at risk for urinary tract symptoms following radiation therapy including the pretreatment status of the bladder, bladder tolerance to the radiation, the fractionation of the radiation, the size of the field, and the total dose of radiation to the bladder (22).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Treatment strategies and urinary tract symptoms results.

Early urinary complications such as irritative bladder symptoms, stress of incontinence, abnormal voiding function, and radiation-induced cystitis can develop from the start of therapy to weeks after completion of treatment. Late complications of pelvic radiation therapy such as urinary incontinence, irritative symptoms, fibrosis, necrosis, late radiation cystitis, hemorrhagic cystitis, bladder ulceration, and vesicovaginal fistula, have been reported from 6 months to 30 years after completing treatment (22).

The prevalence of urinary symptoms following radiation therapy for endometrial cancer is inconsistent. Herwig et al. have reported urinary incontinence in 53.7% of women with stage I endometrial cancer treated with adjuvant radiation therapy (23). Skjeldestad and Hagen have reported on urinary symptoms of 160 women treated for gynecologic cancer in Norway and compared them to 432 age-matched controls. Twenty-one percent of cases were survivors of endometrial cancer and 82.3% of them received adjuvant radiation therapy. These cases were not associated with higher incidence of urinary incontinence compared to controls (24). A randomized trial has reported genitourinary adverse events in 30.0% of early stage endometrial cancer patients treated with radiation and surgery, and in 7.9% of patients with surgery only (25). In another randomized trial, bladder problems were reported in 18% of endometrial cancer patients who had external beam radiation and vaginal brachytherapy, and in 12.3% of patients with vaginal brachytherapy only (26). Soisson et al. have reported that endometrial cancer survivors after radiation and/or chemotherapy had elevated risk for urinary system disorders between 1-5 and >5-10 years after diagnosis. Within 5 years of cancer diagnosis, 37.4% of endometrial cancer patients may be diagnosed with urinary diseases. Their results provide evidence that those treated with RT and/or chemotherapy compared to those treated with surgery alone are at higher risk for urinary system disorders within 5 years of diagnosis (27).

Regarding progestins, Heliovaara-Peippo et al. have found that women treated with LNG-IUS were more likely to experience dysuria at 6 and 12 months compared to those having a hysterectomy. Also, at 12 months, more patients who underwent hysterectomy experienced increased day-time frequency and sensation of incomplete emptying than those who received LNG-IUS. Finally, more women who had undergone hysterectomy reported stress of urinary incontinence compared with those who had LNG-IUS (28). Robinson et al. have found that there was no significant relationship between urinary incontinence and progestin use (29). Finally, interstitial cystitis seems to have a higher prevalence amongst women that have previously used or currently use progestins than those who had no prior use (30).

The different treatment strategies and possible results on urinary tract symptoms are summarized in Table I.

Conclusion

In conclusion, LUTS are an extremely difficult and challenging condition amongst endometrial cancer patients that deteriorate their quality of life. It seems that patients with endometrial cancer receiving surgery and radiotherapy with or without chemotherapy are at higher risk for presenting urinary system disorders than patients receiving surgery or radiotherapy alone. Progestin use seems to have lower risk for LUTS, but, dysuria and interstitial cystitis remain a serious side effect. Additional studies with a large number of patients are needed to fully understand these results, as current literature remains rather scarce on this topic.

Footnotes

  • Authors' Contributions

    Antonios Koutras: interpretation of data, drafting of the manuscript, study conception and design; Angelis Peteinaris: analysis and interpretation of data, drafting of the manuscript; Spyridon Davakis: drafting of themanuscript and analysis and interpretation of data; Georgios Kalinterakis: acquisition of data, drafting of the manuscript; Ioannis Tsilikis: acquisition of data and drafting of the manuscript; Nikolaos Garmpis: drafting of the manuscript and analysis and interpretation of data; Prokopis-Andreas Zotos: drafting of the manuscript and analysis and interpretation of data; Athanasios Chionis: analysis and interpretation of data, drafting of manuscript; Dimitrios Schizas: acquisition of data, drafting of the manuscript, critical revision of the manuscript; Ioannis Karavokyros: acquisition of data, drafting of the manuscript, critical revision of manuscript; Nikolaos Thomakos: acquisition of data, drafting of the manuscript, critical revision of the manuscript; Emmanuel Kontomanolis: acquisition of data, drafting of the manuscript, critical revision of the manuscript; Athanasios Syllaios: analysis and interpretation of data, drafting of the manuscript, study conception and design.

  • Conflicts of Interest

    The Authors declare no potential conflicts of interest regarding this study.

  • Received April 24, 2020.
  • Revision received May 6, 2020.
  • Accepted May 7, 2020.
  • Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Siegel RL,
    2. Miller KD,
    3. Jemal A
    : Cancer statistics, 2019. CA Cancer J Clin 69(1): 7-34, 2019. PMID: 30620402. DOI: 10.3322/caac.21551
    OpenUrlCrossRefPubMed
  2. ↵
    1. Constantine GD,
    2. Kessler G,
    3. Graham S,
    4. Goldstein SR
    : Increased incidence of endometrial cancer following the Women's Health Initiative: An assessment of risk factors. J Womens Health (Larchmt) 28(2): 237-243, 2019. PMID: 30484734. DOI: 10.1089/jwh.2018.6956
    OpenUrlCrossRefPubMed
  3. ↵
    1. Lortet-Tieulent J,
    2. Ferlay J,
    3. Bray F,
    4. Jemal A
    : International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst 110(4): 354-361, 2017. PMID: 29045681. DOI: 10.1093/jnci/djx214
    OpenUrlCrossRef
  4. ↵
    1. Braun MM,
    2. Overbeek-Wager EA,
    3. Grumbo RJ
    : Diagnosis and management of endometrial cancer. Am Fam Physician 93(6): 468-474, 2016. PMID: 26977831.
    OpenUrlPubMed
  5. ↵
    1. Pakish JB,
    2. Lu KH,
    3. Sun CC,
    4. Burzawa JK,
    5. Greisinger A,
    6. Smith FA,
    7. Fellman B,
    8. Urbauer DL,
    9. Soliman PT
    : Endometrial cancer associated symptoms: a case-control study. J Womens Health (Larchmt) 25(11): 1187-1192, 2016. PMID: 27254529. DOI: 10.1089/jwh.2015.5657
    OpenUrlPubMed
  6. ↵
    1. Colombo N,
    2. Creutzberg C,
    3. Amant F,
    4. Bosse T,
    5. González-Martín A,
    6. Ledermann J,
    7. Marth C,
    8. Nout R,
    9. Querleu D,
    10. Mirza MR,
    11. Sessa C,
    12. ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group
    : ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol 27(1): 16-41, 2016. PMID: 26634381. DOI: 10.1093/annonc/mdv484
    OpenUrlCrossRefPubMed
  7. ↵
    1. Homesley HD,
    2. Boike G,
    3. Spiegel GW
    : Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study. Int J Gynecol Cancer 14: 341-347, 2014. PMID: 23546545. DOI: 10.1007/s10147-013-0551-8
    OpenUrl
  8. ↵
    1. Rodolakis A,
    2. Biliatis I,
    3. Morice P,
    4. Reed N,
    5. Mangler M,
    6. Kesic V,
    7. Denschlag D
    : European Society of Gynecological Oncology Task Force for Fertility Preservation. Int J Gynecol Cancer 25(7): 1258-1265, 2015. PMID: 26186070. DOI: 10.1097/IGC.0000000 000000493
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Bradway C,
    2. Coyne KS,
    3. Irwin D,
    4. Kopp Z
    : Lower urinary tract symptoms in women – A common but neglected problem. Journal of the American Academy of Nurse Practitioners 20(6): 311-318, 2008. PMID: 18588658. DOI: 10.1111/j.1745-7599.2008.00329.x
    OpenUrlPubMed
  10. ↵
    1. Cox L,
    2. Rovner ES
    : Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol 6(4): 328-33, 2016. PMID: 26999076. DOI: 10.1097/MOU.00000 00000000283
    OpenUrl
  11. ↵
    1. Abrams P,
    2. Smith AP,
    3. Cotterill N
    : The impact of urinary incontinence on health-related quality of life (HRQoL) in a real-world population of women aged 45-60 years: results from a survey in France, Germany, the UK and the USA. BJU International 115(1): 143-152, 2014. PMID: 24958472. DOI: 10.1111/bju.12852
    OpenUrlPubMed
  12. ↵
    1. Skorupska KA,
    2. Miotła P,
    3. Kubik-Komar A,
    4. Rechberger E,
    5. Adamiak-Godlewska A,
    6. Rechberger T
    : Urinary incontinence after hysterectomy-does type of surgery matter? Ginekol Pol 87(2): 94-97, 2016. PMID: 27306284. DOI: 10.17772/gp/61551
    OpenUrlPubMed
  13. ↵
    1. Whitaker L,
    2. Critchley HO
    : Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 34: 54-65, 2016. PMID: 26803558. DOI: 10.1016/j.bpobgyn.2015.11.012
    OpenUrl
  14. ↵
    1. Abdel Fattah M,
    2. Barrington J,
    3. Yousef M,
    4. Mostafa A
    : Effect of total abdominal hysterectomy in pelvic floor function. Obstet Gynecol Surv 59: 299-304, 2004. PMID: 15024230. DOI: 10.1097/01.ogx.0000120166.84206.dd
    OpenUrlPubMed
  15. ↵
    1. Brown JS,
    2. Sawaya G,
    3. Thom DH,
    4. Grady D
    : Hysterectomy and urinary incontinence: a systemic review. Lancet 356(9229): 535-539, 2000. PMID: 10950229. DOI: 10.1016/S0140-6736(00)02577-0
    OpenUrlCrossRefPubMed
  16. ↵
    1. Parys BT,
    2. Woolfenden KA,
    3. Parsons KF
    : Bladder dysfunction after simple hysterectomy: urodynamic and neurological evaluation. Eur Urol 17: 129-133, 1990. PMID: 2311638. DOI: 10.1159/000464020
    OpenUrlPubMed
  17. ↵
    1. Gustafsson C,
    2. Ekström A,
    3. Brismar S,
    4. Altman D
    : Urinary incontinence after hysterectomy – three-year observational study. Urology 68(4): 769-774, 2006. PMID: 17070350. DOI: 10.1016/j.urology.2006.04.001
    OpenUrlPubMed
  18. ↵
    1. Lakeman MM,
    2. van der Vaart CH,
    3. Roovers JP,
    4. HysVA study group
    : Hysterectomy and lower urinary tract symptoms: a nonrandomized comparison of vaginal and abdominal hysterectomy. Gynecol Obstet Invest 70(2): 100-106, 2010. PMID: 20299800. DOI: 10.1159/000297507
    OpenUrlPubMed
  19. ↵
    1. van der Vaart CH,
    2. van der Bom JG,
    3. de Leeuw JR,
    4. Roovers JP,
    5. Heintz AP
    : The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms. BJOG 109(2): 149-154, 2002. PMID: 11911100. DOI: 10.1016/s1470-0328(02)01332-0
    OpenUrlCrossRefPubMed
  20. ↵
    1. Parazzini F,
    2. Chiaffarino F,
    3. Lavezzari M,
    4. Giambanco V,
    5. VIVA Study Group
    : Risk factors for stress, urge or mixed urinary incontinence in Italy. BJOG 110(10): 927-933, 2003. PMID: 14550363.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Hsieh CH,
    2. Chang WC,
    3. Lin TY,
    4. Su TH,
    5. Li YT,
    6. Kuo TC,
    7. Lee MC,
    8. Lee MS,
    9. Chang ST
    : Long-term effect of hysterectomy on urinary incontinence in Taiwan. Taiwan J Obstet Gynecol 50(3): 326-330, 2011. PMID: 22030048. DOI: 10.1016/j.tjog.2011.07.008
    OpenUrlPubMed
  22. ↵
    1. Erekson EA,
    2. Sung VW,
    3. DiSilvestro PA,
    4. Myers DL
    : Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct 20(2): 159-163, 2009. PMID: 18985266. DOI: 10.1007/s00192-008-0755-z
    OpenUrlPubMed
  23. ↵
    1. Herwig R,
    2. Bruns F,
    3. Strasser H,
    4. Pinggera GM,
    5. Micke O,
    6. Rehder P,
    7. Gozzi C,
    8. Willich N,
    9. Hertle L
    : Late urologic effects after adjuvant irradiation in stage I endometrial carcinoma. Urology 63: 354-358, 2004. PMID: 14972490. DOI: 10.1016/j.urology. 2003.09.040.
    OpenUrlPubMed
  24. ↵
    1. Skjeldestad FE,
    2. Hagen B
    : Long-term consequences of gynecological cancer treatment on urinary incontinence: a population-based cross-sectional study. Acta Obstet Gynecol Scand 87: 469-475, 2008. PMID: 18382876. DOI: 10.1080/00016340801948326
    OpenUrlPubMed
  25. ↵
    1. Sorbe BG,
    2. Horvath G,
    3. Andersson H,
    4. Boman K,
    5. Lundgren C,
    6. Pettersson B
    : External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study–quality-of-life analysis. Int J Gynecol Cancer 22(7): 1281-1288, 2012. PMID: 22864336. DOI: 10.1097/IGC.0b013e3182643ba0
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. White AJ,
    2. Reeve BB,
    3. Chen RC,
    4. Stover AM,
    5. Irwin DE
    : Urinary incontinence and health-related quality of life among older Americans with and without cancer: a cross-sectional study. BMC Cancer 13: 377, 2013. PMID: 23924272. DOI: 10.1186/1471-2407-13-377
    OpenUrlCrossRefPubMed
  27. ↵
    1. Soisson S,
    2. Ganz PA,
    3. Gaffney D,
    4. Rowe K,
    5. Snyder J,
    6. Wan Y,
    7. Deshmukh V,
    8. Newman M,
    9. Fraser A,
    10. Smith K,
    11. Herget K,
    12. Hanson HA,
    13. Wu YP,
    14. Stanford J,
    15. Werner TL,
    16. Setiawan VW,
    17. Hashibe M
    : Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. Gynecol Oncol 148(3): 499-506, 2018. PMID: 29289418. DOI: 10.1016/j.ygyno.2017.12.025
    OpenUrlPubMed
  28. ↵
    1. Heliövaara-Peippo S,
    2. Halmesmäki K,
    3. Hurskainen R,
    4. Teperi J,
    5. Grenman S,
    6. Kivelä A,
    7. Tomas E,
    8. Tuppurainen M,
    9. Paavonen J
    : The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower urinary tract symptoms: a 10-year follow-up study of a randomised trial. BJOG 117(5): 602-609, 2010. PMID: 20156209. DOI: 10.1111/j.1471-0528.2010.02505.x
    OpenUrlPubMed
  29. ↵
    1. Robinson D,
    2. Toozs-Hobson P,
    3. Cardozo L
    : The effect of hormones on the lower urinary tract. Menopause Int 9(4): 155-162, 2013. PMID: 24336244. DOI: 10.1177/1754045313511398
    OpenUrl
  30. ↵
    1. Champaneria R,
    2. D'Andrea RM,
    3. Latthe PM
    : Hormonal contraception and pelvic floor function: a systematic review. Int Urogynecol J 27(5): 709-722, 2016. DOI: 10.1007/s00192-015-2833-3
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Anticancer Research: 40 (6)
Anticancer Research
Vol. 40, Issue 6
June 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Surgical Versus Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Surgical Versus Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms
ANTONIOS KOUTRAS, ANGELIS PETEINARIS, SPYRIDON DAVAKIS, GEORGIOS KALINTERAKIS, IOANNIS TSILIKIS, NIKOLAOS GARMPIS, PROKOPIS-ANDREAS ZOTOS, ATHANASIOS CHIONIS, DIMITRIOS SCHIZAS, IOANNIS KARAVOKYROS, NIKOLAOS THOMAKOS, EMMANUEL KONTOMANOLIS, ATHANASIOS SYLLAIOS
Anticancer Research Jun 2020, 40 (6) 3065-3069; DOI: 10.21873/anticanres.14287

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Surgical Versus Conservative Treatment for Endometrial Cancer in Women of Reproductive Age: Incidence of Urinary Tract Symptoms
ANTONIOS KOUTRAS, ANGELIS PETEINARIS, SPYRIDON DAVAKIS, GEORGIOS KALINTERAKIS, IOANNIS TSILIKIS, NIKOLAOS GARMPIS, PROKOPIS-ANDREAS ZOTOS, ATHANASIOS CHIONIS, DIMITRIOS SCHIZAS, IOANNIS KARAVOKYROS, NIKOLAOS THOMAKOS, EMMANUEL KONTOMANOLIS, ATHANASIOS SYLLAIOS
Anticancer Research Jun 2020, 40 (6) 3065-3069; DOI: 10.21873/anticanres.14287
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Surgical Treatment and Urinary Tract Symptoms
    • Non-surgical Treatment of Endometrial Cancer and Urinary Tract Symptoms
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Sleep Disorders Prior to Adjuvant Radiation Therapy for Gynecological Malignancies
  • Google Scholar

More in this TOC Section

  • Integrated Treatment of Breast Cancer-related Lymphedema: A Descriptive Review of the State of the Art
  • Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
  • Proteolytic Enzyme Therapy in Complementary Oncology: A Systematic Review
Show more Reviews

Similar Articles

Keywords

  • Endometrial cancer
  • surgical treatment
  • chemoradiotherapy
  • progestins
  • urinary tract symptoms
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire